Impact of Dexamethasone, Etoposide, Ifosfamide and Carboplatin as Concurrent Chemoradiotherapy Agents for Nasal Natural Killer/T-Cell Lymphoma

Molecular and Clinical Oncology - United Kingdom
doi 10.3892/mco.2013.123
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Nasal Natural Killer/T Cell Lymphoma

Indian Journal of Hematology and Blood Transfusion
Hematology
2014English

Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type Involving Skin Masquerading as Eczema

Annals of Dermatology
Dermatology
2016English

A Case of Primary Gastric Natural Killer/T-Cell Lymphoma, Nasal Type

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
2007English

Estimation of Radiotherapy Modalities for Patients With Stage I-Ii Nasal Natural Killer T-Cell Lymphoma

Cancer Management and Research
Oncology
2019English

Novel Targets for Natural Killer/T-Cell Lymphoma Immunotherapy

Immunotherapy
OncologyAllergyImmunology
2016English

Addition of Lenalidomide to Rituximab, Ifosfamide, Carboplatin, Etoposide (RICER) in First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma

British Journal of Haematology
Hematology
2014English

Extranodal Natural Killer (Nk)/T-Cell Lymphoma, Nasal Type - Case Report and Review of Czech Lymphoma Study Group (Clsg) Database

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Successful Bridging Chemotherapy With Gemcitabine, Carboplatin, and Dexamethasone Before Unrelated Stem Cell Transplantation for Hepatosplenic T-Cell Lymphoma

Internal Medicine
Internal MedicineMedicine
2019English

First Case of Primary Intraocular Natural Killer T-Cell Lymphoma

BMC Ophthalmology
MedicineOphthalmology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy